Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Israeli Stocks: Can Fite, Glycominds, Orckit Communications

June 5 (Bloomberg) -- Israel’s TA-25 Index rose for the first time in three days, gaining 0.2 percent to 1,230.55 at the 4:30 p.m. close in Tel Aviv. Investors traded about 932.2 million shekels ($277 million) in shares and convertible securities. Local markets will be closed on June 7 and June 8 for a holiday.

The following stocks rose or fell today. Symbols are in parentheses.

Can Fite BioPharma Ltd. (CFBI IT) advanced the most since May 31, increasing 0.3 percent to 0.719 shekels. The biopharmaceutical company signed an agreement to spin off its eye-disease division to U.S. company Denali Concrete Management Inc.

Glycominds Ltd. (GLCM IT) climbed the most since the shares were listed in Tel Aviv on March 1, jumping 9.1 percent to 1.622 shekels. The molecular diagnostics company reported “positive results” in the second clinical trial using gMS-Classifier2 for diagnosis of multiple sclerosis.

Orckit Communications Ltd. (ORCT IT) dropped to the lowest level since February 2003, declining 2.6 percent to 7.806 shekels. The maker of telecommunications equipment said it expects to generate gross proceeds of about 28.9 million shekels from bond offerings.

To contact the reporter on this story: Sharon Wrobel in Tel Aviv at swrobel4@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.